What the FDA labels say about taking them together
Aripiprazole and cariprazine
Cariprazine's FDA label of December 18, 2025 names aripiprazole in its warnings and precautions section; aripiprazole's label does not name cariprazine itself but warns about its class (Atypical antipsychotics).
Check it at the source: the aripiprazole FDA label on DailyMed (effective January 29, 2025, Otsuka America Pharmaceutical, Inc.); the cariprazine FDA label on DailyMed (effective December 18, 2025, Allergan, Inc.).
What does the aripiprazole label say about cariprazine?
Aripiprazole's label does not name cariprazine itself; it warns about its class (Atypical antipsychotics):
Aripiprazole label, boxed warningINCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS and SUICIDAL THOUGHTS AND BEHAVIORS WITH ANTIDEPRESSANT DRUGS Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death.
Aripiprazole label, boxed warningElderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death.
Source: FDA drug label (ABILIFY), Otsuka America Pharmaceutical, Inc., effective January 29, 2025 (SPL set c040bd1d-45b7-49f2-93ea-aed7220b30ac), via openFDA; the full label on DailyMed
What does the cariprazine label say about aripiprazole?
Cariprazine label, warnings and precautionsCerebrovascular Adverse Reactions, Including Stroke, in Elderly Patients with Dementia -Related Psychosis In placebo-controlled trials in elderly patients with dementia, patients randomized to risperidone, aripiprazole, and olanzapine had a higher incidence of stroke and transient ischemic attack, including fatal stroke.
Source: FDA drug label (Vraylar), NDA204370 (Abbvie), as published by Allergan, Inc., effective December 18, 2025 (SPL set 4b5f7c65-aa2d-452a-b3db-bc85c06ff12f), via openFDA; the full label on DailyMed
These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.
Both medicines on the record
| Aripiprazole | Cariprazine | |
|---|---|---|
| Labeled for | Depression, Bipolar disorder, Schizophrenia | Schizophrenia, Bipolar disorder, Depression |
| Boxed warning | Yes | Yes |
| Pharmacy cost (NADAC) | $0.110 per tablet 5 mg tablet | $50.84 per capsule 1.5 mg capsule |
| Shortage now | No current entry | No current entry |
Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)
What next?
- Check more medicines together
- up to five at once